Home › Occupations › Chemists › Madison, WI
Chemists in Madison, WI: H-1B salaries
58 labor condition applications for this occupation with a work site in Madison, WI. Median offered base salary $63,081; middle half $54,080–$73,990.
By wage level
| Wage level | Median salary |
|---|---|
| Level I (entry) | $54,080 |
| Level II (qualified) | $66,373 |
| Level III (experienced) | $68,974 |
| Level IV (fully competent) | $110,400 |
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Employers
| Employer | LCAs | Median salary |
|---|---|---|
| University of Wisconsin System | 30 | $57,200 |
| Catalent Pharma Solutions | 13 | $59,660 |
| Labcorp Early Development Laboratories Inc. | 5 | $65,832 |
| SAFC, Inc. | 3 | $100,000 |
| Labcorp Drug Development Inc. | 1 | $65,707 |
| FUJIFILM Cellular Dynamics, Inc. | 1 | $68,000 |
| Orbia Fluor and Energy Materials USA, Inc. | 1 | $96,305 |
| Nimble Therapeutics Inc. | 1 | $125,000 |
| PPD Development, L.P. | 1 | $76,170 |
| AbbVie Inc. | 1 | $125,000 |
| Splint Pharma LLC | 1 | — |
Job titles
- Research Associate-Postdegree Trainee15
- Scientist I8
- Technician, Biomanufacturing, Downstream/mRNA5
- Staff Scientist I4
- Research Specialist2
- Senior Scientist, Quality Control2
- Senior Scientist, Analytical Development2
- Researcher I2
- Senior Scientist I2
- QC Analyst III, Discovery Research1
- Scientist, API Continuous Flow Process R&D1
- Sr Associate Production Scientist1
- Method Development Scientist III1
- Instrumentation Technologist II-Instrumentation Scientist1
- Principal Scientist, Quality Control1
H-1B sponsors in Madison, WI →
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).